May 13 (Reuters) - Cytokinetics (CYTK.O), opens new tab said on Tuesday its experimental heart disease drug significantly improved patients' ability to exercise compared to standard-of-care ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual ...

IPS HEART has been awarded Orphan Drug Designation (ODD) in the EU by the EUROPEAN MEDICINES AGENCY for GIVI-MPCs unique ability to create new muscle with 100% full length dystrophin in Becker ...

SINGAPORE – A new drug based on gene-editing technology could soon provide respite to patients suffering from a rare and potentially fatal genetic heart disease. Transthyretin amyloid ...

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study. In the ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Researchers determined adding amlodipine to iron chelation therapy improves cardiac parameters in patients with transfusion dependent thalassemia.

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market. Verquvo has been approved to reduce risk of ...

Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous comp ...